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Th2 cytokines increase and stimulate B cells to produce IgG4 in
idiopathic membranous nephropathy
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Th2 cytokines increase and stimulate B cells to produce IgG4
in idiopathic membranous nephropathy.
Background. The predominant deposition of IgG4 in idio-
pathic membranous nephropathy indicates that its presence
characterizes the systemic immune response of the disease.
Methods. We analyzed the expressions of CD3, CD19, CD4,
and CD8 on peripheral blood mononuclear cells (PBMCs) by
flow cytometry, and the levels of glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), interferon (IFN)-c, interleukin
(IL)-4, IL-10, and IL-13 mRNAs in PBMCs using real-time
reverse transcription-polymerase chain reaction (RT-PCR) in
14 patients with idiopathic membranous nephropathy and 14
normal control donors. The levels of IgG subclasses in the B-
cell culture supernatant in the presence or absence of cytokines
were quantified by enzyme-linked immunosorbent assay
(ELISA).
Results. Idiopathic membranous nephropathy patients
showed an increased CD4+/CD8+ ratio, although the num-
bers of peripheral T and B cells were comparable to those
of the normal control group. IL-10 and IL-13 mRNA expres-
sion levels increased in the idiopathic membranous nephropa-
thy group. The levels of spontaneous production of each IgG
subclass by B cells were identical in the two groups. In the
presence of Th2 cytokines, B cells from several individuals
of the idiopathic membranous nephropathy group augmented
the production of IgG4. When the individual levels of each
IgG subclass in the presence of cytokines were compared with
those in the absence of cytokines in each sample, a signifi-
cant increase in the production of IgG4 in the presence of
IL-4 was observed in the idiopathic membranous nephropathy
group.
Conclusion. These results indicate that the altered functions
of T cells to produce Th2 cytokines and the increased production
of IgG4 by B cells in response to these cytokines characterize
the immune response in idiopathic membranous nephropathy.
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Research into the pathogenesis of idiopathic mem-
branous nephropathy has centered primarily on anti-
gen identification. The understanding of the disease has
been greatly advanced by the Heymann nephritis model,
a rat experimental model of idiopathic membranous
nephropathy. In this experimental model, megalin, a com-
mon component in the tubular and glomerular epithelial
cells, was identified as a target antigen [1–3]. Further-
more, this model demonstrated the critical role of C5b-
9–induced podocyte injury [4, 5] and podocyte response
[6–9], which result in proteinuria. However, megalin does
not exist in human podocytes, and the target antigen in hu-
man idiopathic membranous nephropathy has not been
identified. Although the rat Heymann nephritis model
provided the molecular mechanisms of proteinuria, the
antigen-specific immune response in this model is not
applicable to the corresponding human disease. Stud-
ies using human samples are required to elucidate the
nephritogenic immune responses in idiopathic membra-
nous nephropathy.
Some attempts to define the pathogenesis of idiopathic
membranous nephropathy have been made using biopsy
samples or the peripheral blood of patients, and several
immunologic abnormalities have been described. For ex-
ample, previous studies showed an imbalance between
the CD4+ and CD8+ subsets [10–15], diminished synthe-
sis of immunoglobulin by peripheral lymphocytes [16],
decreased suppressor T-cell function [11, 13, 17], and pre-
dominance of the Th2 immune response [18, 19] in idio-
pathic membranous nephropathy. Furthermore, several
reports have shown that IgG4 predominates in the renal
biopsies of idiopathic membranous nephropathy [20–23]
and this predominance is not observed in secondary or
lupus-associated membranous nephropathy. Moreover,
Doi et al [24] showed that IgG4 is overrepresented in
the circulating immune complex in idiopathic membra-
nous nephropathy. These observations suggest that im-
mune response in idiopathic membranous nephropathy
may be characterized by the presence of IgG4. In this
study, to understand the immune responses in idiopathic
membranous nephropathy, we focused on the production
and regulation of IgG4. We analyzed the subpopulations
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and functions of peripheral lymphocytes, including the in
vitro production of IgG subclasses by B cells and their
responses to the cytokines.
METHODS
Subjects
Venous blood samples were obtained 2 or 3 days
after the biopsy, when the diagnosis of idiopathic mem-
branous nephropathy was highly indicated by a rou-
tine immunofluorescence study, which was performed 2
days after the biopsy. Among these, 14 patients were
selected to participate in the study on the basis of the
diagnosis of idiopathic membranous nephropathy con-
firmed by light and electron microscopy. These patients
were confirmed to have no systemic disease that may
cause secondary membranous nephropathy by clinical
and laboratory examinations. Their clinical and labo-
ratory parameters were nine males and five females,
mean age 60.4 ± 15.0 years, mean urinary protein ex-
cretion 2.5 ± 3.7 g/day, mean serum total protein 5.8 ±
1.2 g/dL, mean serum albumin 3.0 ± 1.1 g/dL, mean serum
creatinine 0.9 ± 0.4 mg/dL, and mean creatinine clear-
ance 79.5 ± 39.5 mL/min. The histologic stage was classi-
fied into four stages according to the electron microscopic
findings. One patient was classified as stage I, eight pa-
tients as stage II, four patients as stage III, and one pa-
tient as stage IV. For the normal controls, venous blood
samples were obtained from 14 age-matched (mean 54 ±
19 years), healthy volunteers, whose renal function and
urinary sediment were proved to be normal in routine
medical examinations. None of the patients had received
any immunosuppressive drugs, including steroids, at the
time of sample collection. Informed consent was obtained
from all patients and healthy volunteers.
Glomerular IgG subclasses
Glomerular IgG subclass deposition was examined
by direct immunofluorescence microscopy, using fluo-
rescein isothiocyanate (FITC)-conjugated mouse mon-
oclonal antibodies as follows: clone HP-6069 (Zymed
Laboratories, San Francisco, CA, USA) (anti-IgG1), HP-
6014 (Sigma Chemical Co., St. Louis, MO, USA) (anti-
IgG2), HP-6047 (Zymed Laboratories) (anti-IgG3), and
HP-6025 (Sigma Chemical Co.) (anti-IgG4). The fluores-
cence intensity of glomerular staining was graded as fol-
lows: negative, 0; very weak, 0.5; weak, 1; moderate, 2;
and strong, 3, and scored for each specimen. The results
are expressed as the frequency of positive biopsies and
the intensity of fluorescence for each IgG subclass.
Cytofluorometric analysis
Peripheral blood mononuclear cells (PBMCs) were
isolated by centrifugation over a Ficoll-Hypaque gra-
dient. PBMCs were stained with the following combi-
nations of monoclonal antibodies: anti-CD3/FITC (BD
PharMingen, San Diego, CA, USA) and anti-CD 19/PE
(BD PharMingen), to analyze T and B lymphocytes;
anti-CD3/Cy (BD PharMingen), anti-CD8/FITC (BD
PharMingen), and anti-CD4/PE (BD PharMingen), to
analyze the CD4+ and CD8+ subsets of T lymphocytes.
Flow cytometry results were analyzed using Cell Quest
software.
RNA preparation and cDNA synthesis
Total RNA was prepared from peripheral whole blood
using an RNA Blood Mini Kit (Qiagen GmbH, Hilden,
Germany). cDNA was synthesized with 5 lg of total RNA
using an oligo(dT) primer (Invitrogen, Carlsbad, CA,
USA), deoxynucleoside triphosphate (dNTP) (Promega,
Madison, WI, USA), RNase inhibitor (Invitrogen), and
a SuperScript RT kit (Life Technologies, Inc., Gaithers-
burg, MD, USA) containing 5 × reverse transcription
(RT) buffer, 0.1 mol/L dithiothreitol (DTT) and reverse
transcriptase.
Cytokine mRNA levels in PBMCs
Real-time quantitative polymerase chain reaction
(PCR) was carried out using a Light Cycler Instrument,
and the DNA binding dye SYBR Green I for the de-
tection of PCR products. The target molecules were
glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
interferon (IFN)-c, interleukin (IL)-4, IL-10, and IL-
13. Reaction mixtures for the real-time PCR had a fi-
nal volume of 20 lL consisting of 10 lL of cDNA,
2 lL of commercially synthesized primers (LightCy-
clerTM Primer Set, Roche GmbH, Heidelberg, Germany),
2 lL of Faststart SYBR Green I (Roche GmbH), and
6 lL of distilled water. Amplification conditions were
10 minutes at 95◦C and 35 cycles of 10 seconds at 95◦C,
10 seconds at 68◦C, and 16 seconds at 72◦C. The quantifi-
cation of gene expression was performed using the am-
plification standards contained in the kit. Cytokine gene
expression was expressed in relative copy number nor-
malized against GAPDH mRNA expression level.
Enzyme-linked immunosorbent assay (ELISA) of IgG
subclasses
IgG subclass concentrations in supernatants were
quantitated by ELISA as described previously [22].
Briefly, microtiter plates (Nunc, Roskilde, Denmark)
were coated with one of the human IgG subclass spe-
cific mouse monoclonal antibodies (Calbiochem Corp.,
La Jolla, CA, USA) at 5 lg/mL for HP6069 (anti-IgG1),
HP6002 (anti-IgG2), and HP6025 (anti-IgG4), and at 2.5
lg/mL for HP6047 (anti-IgG3). Samples were then added
to the microtiter plates. The assays were developed with
304 Kuroki et al: Th2 cytokines, IgG4 and idiopathic membranous nephropathy
Table 1. Glomerular IgG subclass distribution
IgG1 IgG2 IgG3 IgG4
Number of positive biopsies (%) 3 (27.3) 2 (18.2) 1 (9.1) 11 (100)
Intensity of fluorescencea (mean ± SD) 0.18 ± 0.44 0.18 ± 0.40 0.09 ± 0.30 1.09 ± 0.49
Glomerular IgG subclass distribution was studied in 11 patients with idiopathic membranous nephropathy.
aIntensity of fluorescence is expressed as a score.
alkaline phosphatase (AP)-conjugated mouse polyclonal
antihuman IgG antibody (Jackson Immunoresearch Lab-
oratories Inc., West Grove, PA, USA). For each assay, the
standard curve was established using the human standard
serum NOR-01/91 (Nordic Immunological Laboratories,
Tilburg, The Netherlands).
Isolation of peripheral B cells
B cells were isolated by negative selection from PBMCs
using a cross-linking reagent (RosetteSepTM antibody
cocktail for human B cells) (Stemcell Technologies Inc.,
British Columbia, Canada), which is a mixture of mouse
and rat monoclonal antibodies. These antibodies are
bound in bispecific antibody complexes, which are di-
rected against cell surface antigens for human hematopoi-
etic cells (CD2, CD3, CD16, CD36, and CD56) and
glycophorin A on red blood cells. The cell fractions ob-
tained contained >95% CD19+ B cells as estimated by
flow cytometry.
In vitro production of IgG subclasses by B cells
B cells were cultured at a concentration of 2 × 105
cells/well in 96-well plates in a final volume of 0.2 mL of
Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 2 mmol/L glutamine, 10% fetal calf serum
(FCS), 100 U/mL penicillin, and 100 lg/mL strepto-
mycin. On the basis of a preliminary kinetic experiment
showing that isolated B cells produce IgG without any
stimulation and the levels of IgG subclasses reach the
maximum after 7 days of incubation (data not shown), the
supernatants were harvested on day 7 of incubation and
the levels of IgG subclasses were measured by ELISA.
B cells were also cultured in the presence of 50 ng/mL
of IFN-c (R&D Systems, Abington, UK), IL-4 (Geneva
Biochemical Research Institute, Geneva, Switzerland),
IL-10 (R&D Systems), or IL-13 (R&D Systems) to deter-
mine the effect of these cytokines on IgG subclass produc-
tion. The concentrations of cytokines were determined
on the basis of a preliminary experiment using isolated
B cells from healthy volunteers showing that these cy-
tokines had no dose-dependent effects on IgG subclass
production in the range of 0.5 to 50 ng/mL. To assess the
influence of cytokines on the IgG subclasses, the increase
ratio of cytokine-stimulated IgG subclass synthesis by B
cells was calculated using the following formula for indi-
vidual samples: increase ratio = (IgG subclass level in the
presence of cytokines)/(IgG subclass level in the absence
of cytokines).
Statistical analyses
Comparisons were done using the Mann-Whitney U
test, and correlations were tested by Spearman rank cor-
relation, performed with StatView 5. P values greater
than 5% were considered insignificant.
RESULTS
IgG4 was the major glomerular IgG subclass
in idiopathic membranous nephropathy
Glomerular IgG subclasses were examined in 11 pa-
tients with idiopathic membranous nephropathy. As
shown in Table 1, IgG4 was the major glomerular IgG
subclass, both in the fluorescence intensity and in the
frequency of positivity. These results were consistent
with those of previous reports. There was no correla-
tion between the fluorescence intensity of the staining
of IgG4 and the ultrastructural stages of glomerular
lesions.
Percentage of CD4+ T cells increased in patients
with idiopathic membranous nephropathy
According to the results for the glomerular IgG sub-
classes, IgG4 subclass antibodies seem to be pivotal
in the immunopathogenesis of idiopathic membranous
nephropathy. To study the possible alterations in the pro-
duction of IgG4 and its regulation, we first examined the
peripheral lymphocytes by flow cytometry. The numbers
of peripheral lymphocytes, T cells, and B cells were not
significantly different between the two groups (Fig. 1A to
C). However, in the idiopathic membranous nephropathy
group, fluorescence-activated cell sorter (FACS) analysis
showed a significant increase in the percentage of CD4+
T cells, and a significant decrease in the number of CD8+
T cells, resulting in a marked increase in the CD4+/8+
ratio (Fig. 1D to F). These alterations in the lymphocyte
subpopulations did not correlate with the levels of uri-
nary protein, serum total protein, or albumin. These re-
sults indicate that the elevated CD4+/8+ ratio in patients
with idiopathic membranous nephropathy was not a con-
sequence of proteinuria.
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Fig. 1. Peripheral lymphocyte subpopulations in patients with idiopathic membranous nephropathy (MN) and normal controls (NC). The numbers
of lymphocytes were calculated based on the results of flow cytometry. (A) Numbers of the peripheral lymphocytes. (B) Percentages of CD3+ T
cells and CD19+ B cells. (C) Numbers of CD3+ T cells and CD19+ B cells. (D) Percentages of CD4+ T cells and CD8+ T cells. (E) Numbers of
CD4+ T cells and CD8+ T cells. (F) CD4+/8+ ratio. Each column and bar represents the mean and 1 SD. The numbers of lymphocytes, both T and
B cells were identical in the two groups. The idiopathic membranous nephropathy patients showed an increased percentage of CD4+ T cells, and a
decreased number of CD8+ T cells, resulting in a high CD4+/8+ ratio.
IL-10 and IL-13 mRNA expression levels in PBMCs
increased in idiopathic membranous nephropathy
Because cytokines have an effect on the production
of IgG subclasses, patients with idiopathic membra-
nous nephropathy may exhibit distinct cytokine patterns.
Therefore, we quantified the mRNA levels of IFN-c, IL-
4, IL-10, and IL-13 in PBMCs using real-time RT-PCR.
There were no differences in the levels of IFN-c and IL-4
mRNAs between the idiopathic membranous nephropa-
thy group and the normal control group (Fig. 2A and
B). In contrast, the relative copy numbers of IL-10 and
IL-13 were significantly higher in the idiopathic membra-
nous nephropathy group than in the normal control group
(Fig. 2C and D).
In vitro production of IgG subclasses by B cells
B cells are responsible for the production of im-
munoglobulins, and thus the function of B cells to
produce IgG subclasses may be altered in patients with
idiopathic membranous nephropathy. To investigate this
possibility, we analyzed the levels of IgG subclasses in
the culture supernatants of isolated B cells. As shown in
Fig. 3A, unstimulated B cells produced measurable
amounts of IgG subclasses in both groups. Although B
cells from three patients with idiopathic membranous
nephropathy showed a higher spontaneous production of
IgG4, there was no significant difference in the concen-
trations and percentage of each IgG subclass, including
IgG4, between the idiopathic membranous nephropathy
group and the normal control group. The levels of total
IgG were also identical in the two groups. Without stimu-
lation, B cells from patients with idiopathic membranous
nephropathy showed no significant change in the produc-
tion of IgG subclasses.
Correlation between immunologic alterations and
glomerular depositions of IgG4
Alterations in immune response may lead to the
glomerular deposition of IgG4 in membranous nephropa-
thy. Therefore, we analyzed the association between im-
munologic alterations and the fluorescence intensity of
staining of glomerular IgG4 in each patient. There was no
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Fig. 2. Cytokine mRNA levels in periph-
eral blood mononuclear cells (PBMCs). Cy-
tokine mRNA levels were quantified using
real-time reverse transcription-polymerase
chain reaction (RT-PCR) and results were
expressed in relative copy numbers nor-
malized against glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) mRNA level. (A)
Interferon (IFN)-c. (B) Interleukin (IL)-4.
(C) IL-10. (D) IL-13. Each column and bar
represents the mean and 1 SD. The levels of
Th2 cytokines IL-10 and IL-13 increased in the
idiopathic membranous nephropathy (MN)
group. NC is normal controls.
correlation between the mRNA expression levels of cy-
tokines and the concentrations or ratios of IgG subclasses
in patients with idiopathic membranous nephropathy.
Furthermore, the mRNA expression levels of cytokines
and the concentrations or ratios of IgG subclasses did
not correlate with the fluorescence intensity of staining
of glomerular IgG4 in these patients.
IL-4 enhances in vitro production of IgG4 by B cells in
idiopathic membranous nephropathy
The above results showing that cytokine patterns differ
in the idiopathic membranous nephropathy patients raise
the possibility that these cytokines affect the production
of IgG subclasses by B cells. To investigate the influence
of cytokines on the production of IgG subclasses, we cul-
tured B cells in the presence of 50 ng/mL of IFN-c (N =
13), IL-4 (N = 13), IL-10 (N = 12), or IL-13 (N = 11).
Figure 3B shows that the presence of IFN-c had no ef-
fect on the production of IgG subclasses in either group.
As shown in Figure 3C, D, and E, B cells from some of
the idiopathic membranous nephropathy patients pro-
duced increased amounts of IgG4 in the presence of IL-
4, IL-10, or IL-13. However, no significant difference was
observed in the concentrations of IgG4 and the other
three IgG subclasses in the presence of these cytokines
between the two groups. Moreover, a comparison of the
levels of each IgG subclass in the presence and absence
of cytokines showed no significant difference in both
groups. To evaluate the influence of cytokines in more
detail, we compared the levels of IgG subclasses in the
presence and absence of cytokines in single individuals,
and expressed the results as increase ratio. When the in-
crease ratio of each IgG subclass was compared between
the two groups, the mean increase ratios of IgG4 in the
presence of IL-4 were significantly higher in the idio-
pathic membranous nephropathy group, although those
of IgG1, IgG2, and IgG3 were not significantly differ-
ent (Fig. 4). In the presence of IFN-c, IL-10, or IL-13,
no significant difference was observed in the increase
ratio of IgG subclasses between the two groups. These
results indicated that IL-4 enhanced the in vitro pro-
duction of IgG4 by B cells in idiopathic membranous
nephropathy.
DISCUSSION
The precise nature of the disease-initiating antigen
in human idiopathic membranous nephropathy remains
unclarified, despite the fact that the rat Heymann nephri-
tis model has afforded insight into the pathogenesis of
the disease. On the basis of the findings that the num-
ber of IL-10- or IL-4-secreting T cells increases in idio-
pathic membranous nephropathy [18, 19] and that IgG4,
which is considered to be a human homologue of murine
Th2-type subclass IgG1, predominates in glomerular IgG
subclasses in idiopathic membranous nephropathy, it has
been suggested that the disease-initiating antigen trig-
gers Th2-type immune responses in idiopathic membra-
nous nephropathy. Although the validity of the Th1/Th2
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Fig. 3. IgG subclass production by B cells. B cells were cultured in the absence (A) or presence of cytokines. (B) Interferon (IFN)-c. (C) Interleukin
(IL)-4. (D) IL-10. (E) IL-13. After 7 days of incubation, the levels of IgG subclasses in the supernatant were quantified. For the concentrations,
the scales on the left side are for total IgG, IgG1, and IgG2, and the scales on the right side are for IgG3 and IgG4. Percentages are expressed as
the mean and 1 SD. Open circles and bars represent normal controls, and closed circles and bars represent idiopathic membranous nephropathy.
Although some B cells from idiopathic membranous nephropathy patients augmented the production of IgG4 in response to IL-4, IL-10, or IL-13,
there was no significant difference in the concentration and percentage of each IgG subclass between the two groups.
paradigm in humans is not universally accepted, the im-
mune responses in idiopathic membranous nephropathy
have been simplified as “Th2 predominance,” and no fur-
ther attempts have been made to clarify the association
between these cytokines and the production of IgG4.
Therefore, in this study, we analyzed the functions of pe-
ripheral lymphocytes in patients with idiopathic mem-
branous nephropathy, to define the characteristics of the
immune response, which may be useful to elucidate the
causal antigen of the disease. We observed an increased
CD4+/CD8+ratio, higher levels of IL-10 and IL-13
mRNAs in PBMCs, and increased in vitro production of
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Fig. 4. To assess the effect of cytokines on
the production of IgG subclasses in individ-
ual samples, the increase ratio was calculated.
(A) Interferon (INF)-c. (B) Interleukin (IL)-
4. (C) IL-10. (D). IL-13. Columns and bars
indicate the mean and 1 SD of increase ratios
for each group. The mean increase ratio of
IgG4 in the presence of IL-4 in the idiopathic
membranous nephropathy group was signifi-
cantly higher than that in the normal control
group.
IgG4 by B cells in the presence of IL-4, in the patients
with idiopathic membranous nephropathy.
Previous studies of the T-cell subsets in idiopathic
membranous nephropathy demonstrated an increased
CD4+/CD8+ ratio [10–15], which was consistent with our
findings. The observation that the CD4+/CD8+ ratio re-
turned to the normal level in the persistent stage or in the
complete remission of the disease [14, 15] raises the possi-
bility that these alterations of T-cell subsets are the conse-
quences of proteinuria. Our finding that the CD4+/CD8+
ratio did not correlate to the amount of urinary protein
indicates that this imbalance of T cells in idiopathic mem-
branous nephropathy patients was not secondary to pro-
teinuria. However, since abnormalities of T-cell subsets
are also observed in patients with IgA nephropathy [10,
12, 13], we cannot consider this imbalance as a pathologic
status specific to idiopathic membranous nephropathy.
It is crucial to determine whether these alterations in
T-cell subsets are associated with functional changes in
patients with idiopathic membranous nephropathy. Sev-
eral studies showed the defective [12, 13, 17] concanavalin
A (Con A)–inducible functions of suppressor T cells
in idiopathic membranous nephropathy. Because whole
PBMCs were used in these studies, the impaired suppres-
sor cell function may not reflect a functional change, but
could be a result of the decreased number of CD8+ T
cells. The assessment of cytokine patterns is one of the
approaches to determining the functions of T cells. Hi-
rayama et al [18], using flow cytometry, found a decreased
number of IL-2–positive CD4+ T cells and an increased
number of IL-10–positive CD4+ T cells in patients with
idiopathic membranous nephropathy, although there was
no significant difference in the number of IFN-c–positive
or IL-4–positive CD4+ T cells. In contrast, Masutani et al
[19] demonstrated the up-regulation of IL-4 production
by CD4+ T cells, using the same method. In the present
study, we used quantitative real-time RT-PCR to assess
the cytokine patterns, a method which has been proved
to be sensitive [25] for IL-4 detection, which is difficult in
humans. Thus, we were able to determine cytokine pat-
terns without any stimulation of PBMCs and observed
increased expression levels of IL-10 and IL-13 mRNAs in
idiopathic membranous nephropathy patients, although
those of IFN-c and IL-4 were not significantly different
from those in the normal control group. In contrast to
Masutani et al [19], we could not demonstrate a sig-
nificant change in IL-4 mRNA expression level in
the idiopathic membranous nephropathy group. The
discrepancy may be due to the method of detecting
IL-4. Ekerfelt et al [25], who compared three assays
[(ELISPOT), ELISA, and real-time RT-PCR] that can
detect IL-4 showed that mRNA expression levels do not
correlate with the secretion of IL-4 [25]. Accordingly, our
results of the expression levels of IL-4 mRNA were dif-
ferent from the results of the study by Masutani et al,
in which IL-4 production was analyzed. Moreover, since
the amount of blood samples obtained was not suffi-
cient to sort out CD4+ T cells, we used whole PBMCs
for RNA extraction. For this reason, our results did not
precisely reflect the functional changes of T cells. Never-
theless, our observations, together with the two previous
findings indicate that idiopathic membranous nephropa-
thy results from the predominance of Th2-type immune
response.
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There have been two studies that analyzed the in vitro
production of IgG, but not its subclasses, using whole
PBMCs from idiopathic membranous nephropathy pa-
tients [13, 16], which may interfere with the production
of IgG by B cells. We used purified B cells to closely eval-
uate the functions of B cells, avoiding the interference of
other peripheral mononuclear cells. The functional tests
showed that B cells augmented IgG4 synthesis when stim-
ulated by Th2 cytokines in some individuals in the id-
iopathic membranous nephropathy group, although the
spontaneous production of all four IgG subclasses was
similar to that of the normal control group. Human pe-
ripheral B cells can be divided into two distinct popula-
tions: naı¨ve B cells (60%) and memory B cells (40%) [26],
with only the latter group being able to produce IgG when
stimulated in vitro [27]. It is unlikely that class switching
occurred in our culture system, since CD40 stimulation
with cytokines induces a differentiation blockade of naı¨ve
B cells [27] and a prolonged CD40 stimulation is neces-
sary for the naı¨ve B cells to switch to CD27-positive mem-
ory B cells [28]. Accordingly, one possible explanation
for our results is that although the number of peripheral
B cells did not change, as confirmed by flow cytometry,
the percentage of memory or previously activated circu-
lating B cells increased in the patients with idiopathic
membranous nephropathy, the cells being ready to pro-
duce IgG4 in response to Th2 cytokines. Furthermore,
the expression levels of cytokine receptors on B cells can
account for the responsiveness to the cytokines. B cells
would respond highly to IL-4, when the IL-4 receptor is
up-regulated, albeit the expression level of IL-4 mRNA
was not significantly increased. To confirm these hypothe-
ses, further analysis of B cell surface markers, for exam-
ple, CD20 (marker of activated B cells), CD27 (marker
of memory B cells) [29], and CD124 (IL-4 receptor), will
be necessary. Recent studies that show an increased per-
centage of CD20-positive B cells in patients with idio-
pathic membranous nephropathy [30, 31] support our
hypotheses.
The elucidation of the target antigen is of the utmost
importance in terms of understanding the pathogenesis
of human idiopathic membranous nephropathy. Neutral
endopeptidase is one of the antigens shared by the brush
border and podocytes that are involved in the formation
of immune deposits in animal models; this protein is also
expressed on human podocytes. Recently, Debiec et al
[32] have reported a case of antenatal idiopathic mem-
branous nephropathy due to antineutral endopeptidase
antibodies, which were transferred from a mother who
was deficient in neutral endopeptidase and was thought to
be immunized against the antigen at the time of an earlier
miscarriage. However, this antigen-antibody response is
not generally applicable to the pathogenesis of idiopathic
membranous nephropathy. The functional alterations of
peripheral B cells to produce IgG4 in the presence of cy-
tokines observed in the present study provide some clues
to the characteristics of the disease-specific antigen in id-
iopathic membranous nephropathy. The IgG4 subclass
predominance has been observed for autoantibodies to
thyroglobulin and microsomes in Hashimoto’s thyroiditis
[33], autoantibodies to the muscle-specific kinase in myas-
thenia gravis [34], autoantibodies in pemphigus vulgaris
[35], and autoantibodies to glomerular basement mem-
brane in Goodpasture’s syndrome [36]. Thus, in these
organ-specific autoimmune diseases, autoantibodies to
organ components often belong to the IgG4 subclass.
Accordingly, a strong candidate for the disease-specific
antigen in idiopathic membranous nephropathy may be a
molecule expressed in the glomerulus, or more exactly, in
podocytes. On the other hand, IgG4 is produced after re-
current stimulation with antigens [37]: blocking antibod-
ies following specific allergen therapy belong mainly to
this subclass [38] and the shift to IgG4 is noted in chronic
helminth infection [39]. Consequently, chronic infections,
in which antibodies of the IgG4 subclass generated in re-
sponse to an infectious agent cross-react with a compo-
nent of podocytes, can initiate idiopathic membranous
nephropathy. However, to date, there is no evidence of
chronic infections in idiopathic membranous nephropa-
thy. Isotype switching to IgG4 is dependent not only on
antigenic stimulation, but also on regulatory factors pro-
duced by T cells. As mentioned already, the evidence for
Th2 predominance in idiopathic membranous nephropa-
thy observed in this study is in accordance with the im-
portance of IgG4 in this disease.
T cells from thymic precursors initially express both
the CD4 and CD8 coreceptors, and then become ei-
ther CD4 or CD8 single-positive thymocytes. The precise
mechanism of this coreceptor-defined lineage remains
unknown. Interestingly, a more recent study showed that
the CD4 versus CD8 lineage of immature thymocytes
is controlled by the coreceptor-influenced duration of
the initial T-cell receptor signaling. Long-lasting signals
would be necessary to induce the CD4 program [40]. Al-
though the results from the in vitro experiment are not di-
rectly applicable to our observation of peripheral T cells,
they may explain the increased CD4+/8+ ratio, further
suggesting the presence of a prolonged stimulation in id-
iopathic membranous nephropathy.
Our study demonstrated the predominance of IgG4
in renal biopsies and showed that the functions of both
T and B cells are altered in idiopathic membranous
nephropathy, resulting in Th2 predominance and in-
creased production of IgG4 by B cells in response to these
cytokines. Although the precise nature of the disease-
initiating antigen in idiopathic membranous nephropa-
thy remains unknown, our findings provide the charac-
teristics of the disease-specific immune response, which
has implications for a new therapeutic approach to the
disease.
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